LifeMine Therapeutics, a company that analyzes fungal genomes to find molecules that have potential as new medicines, has raised $175 million in financing. Among the investors is GlaxoSmithKline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback